There were eight favorable prognostic genes and six poor prognostic genes incorporated in this signature, and a variety of OSRGs such as CD38, FOXO1, HGF, IL18BP, and TRPM2 were closely involved in the previous studies regarding cancer subtypes and immune landscape. The gene discussed is CD38; the disease is cancer.